Trellus Management Company’s TherapeuticsMD TXMD Stock Holding History

Trellus Management Company’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$13K	–	72
2020 Q2	$13K	Buy	+200	New	+$11.6K	0.01%	54
2018 Q2	–	Sell	-1,300	Closed	-$317K	–	72
2018 Q1	$317K	Buy	+1,300	New	+$365K	0.58%	46
2015 Q2	–	Sell	-1,300	Closed	-$393K	–	116
2015 Q1	$393K	Sell	1,300 -200	-13%	-$48.8K	0.47%	61
2014 Q4	$334K	Buy	1,500 +238	+19%	+$49.1K	0.49%	56
2014 Q3	$293K	Buy	1,262 +534	+73%	+$135K	0.25%	84
2014 Q2	$161K	Buy	+728	New	+$162K	0.14%	110

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Trellus Management Company's TXMD Position: Q3 2020 in Review

Trellus Management Company sold out of TherapeuticsMD (TXMD) in Q3 2020, closing a stake of 200 shares — an estimated $13K sold.

Trellus Management Company first reported a position in TXMD in Q2 2014 and held it in 6 quarters. The position peaked at $393K in Q1 2015. 142 funds tracked by Wall St. Rank hold TXMD as of Q3 2020.

Trellus Management Company reported no remaining TherapeuticsMD position as of Q3 2020 after selling out during the quarter.
Trellus Management Company sold 200 TherapeuticsMD shares in Q3 2020, an estimated $13K.
Trellus Management Company first reported a position in TherapeuticsMD in Q2 2014 and held it in 6 quarters.
Trellus Management Company's TherapeuticsMD position peaked at $393K in Q1 2015.
142 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2020.

Based on Trellus Management Company's 13F filing for Q3 2020, filed 20 Oct 2020.